Eric C. Ko
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in ⓘ
-
- Chemical Reactions and Isotopes 4
- Oncology 15
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 4
- Co-authors
- Silvia C. Formenti (6 shared papers)David Raben (1 shared paper)Johnny Kao (6 shared papers)Soldano Ferrone (7 shared papers)Samuel Eisenstein (3 shared papers)Shibo Fu (4 shared papers)Andrew G. Sikora (2 shared papers)Xinhui Wang (4 shared papers)
- Journals
- Canadian Journal of Chemistry (8 papers)The Journal of Immunology (3 papers)Journal of the American Chemical Society (3 papers)PLoS ONE (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Eric C. Ko
47 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Oncology 530
- Immunology 402
- Otorhinolaryngology 53
- Pulmonary and Respiratory Medicine 314
- Cancer Research 109
Countries citing papers authored by Eric C. Ko
This map shows the geographic impact of Eric C. Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. Ko more than expected).
Fields of papers citing papers by Eric C. Ko
This network shows the impact of papers produced by Eric C. Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. Ko. The network helps show where Eric C. Ko may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric C. Ko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 195 | |
| 2 | 2010 | 119 | |
| 3 | 2015 | 90 | |
| 4 | 2018 | 84 | |
| 5 | 2019 | 57 | |
| 6 | 1999 | 57 | |
| 7 | 2012 | 56 | |
| 8 | 2013 | 51 | |
| 9 | 2018 | 46 | |
| 10 | 2000 | 40 | |
| 11 | 2006 | 36 | |
| 12 | 2011 | 30 | |
| 13 | 2003 | 29 | |
| 14 | 2012 | 25 | |
| 15 | 2005 | 23 | |
| 16 | 2004 | 20 | |
| 17 | 2005 | 19 | |
| 18 | 2011 | 18 | |
| 19 | 2007 | 16 | |
| 20 | 2020 | 16 |
About Eric C. Ko
Eric C. Ko is a scholar working on Pharmaceutical Science, Oncology, Spectroscopy, Immunology and Otorhinolaryngology, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (8 papers), Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Chemical Reactions and Isotopes (4 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (530 citations), Immunology (402 citations), Otorhinolaryngology (53 citations), Pulmonary and Respiratory Medicine (314 citations) and Cancer Research (109 citations). Eric C. Ko has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Silvia C. Formenti, David Raben, Johnny Kao, Soldano Ferrone, Samuel Eisenstein, Shibo Fu, Andrew G. Sikora, Xinhui Wang, Wei Luo and Richard G. Stock. Their work appears in journals such as Canadian Journal of Chemistry, The Journal of Immunology, Journal of the American Chemical Society, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.